Raymond James Financial’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450M Buy
4,348,680
+889,195
+26% +$79.4M 0.12% 136
2026
Q1
$248M Buy
3,459,485
+14,296
+0.4% +$1.1M 0.08% 229
2025
Q4
$273M Buy
3,445,189
+344,071
+11% +$27.1M 0.09% 207
2025
Q3
$234M Sell
3,101,118
-90,466
-3% -$6.2M 0.08% 236
2025
Q2
$220M Buy
3,191,584
+133,875
+4% +$8.78M 0.08% 234
2025
Q1
$207M Buy
3,057,709
+472,880
+18% +$28.3M 0.08% 233
2024
Q4
$116M Buy
+2,584,829
New +$145M 0.04% 383

Other funds holding CVS

Raymond James Financial's CVS Position: Q2 2026 in Review

Raymond James Financial increased its CVS Health (CVS) stake by 26% in Q2 2026, buying an estimated $79.4M and bringing the position to 4,348,680 shares worth $450M. The position accounts for 0.12% of the portfolio, ranked #136.

Raymond James Financial first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Raymond James Financial held 4,348,680 shares of CVS Health worth $450M as of Q2 2026.
  • Raymond James Financial bought 889,195 CVS Health shares in Q2 2026, an estimated $79.4M.
  • CVS Health made up 0.12% of Raymond James Financial's portfolio in Q2 2026, its #136 holding.
  • Raymond James Financial first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.